Arianna Ferrari Christopher Coenen Armin Grunwald Arnold Sauter ...

Tabbert, T. (2004): Menschmaschinengötter – Künstliche Menschen in Lite-
ratur und Technik. Fallstudien einer Artifizialanthropologie. Artislife Press:
Hamburg.
Takahashi K., Yamanaka S. (2006): Induction of pluripotent stem cells from
mouse embryonic and adult fibroblast cultures by defined factors, Cell 126:
663–676.
Tallacchini M. (2008): Defining an appropriate ethical, social and regulatory
framework for clinical xenotransplantation,
Current Opinion in Organ Transplantation 13(2):159–64.
Talwar S.K., Xu S., Hawley E.S. et al. (2002): Behavioural neuroscience:
Rat navigation guided by remote control, Nature 417: 37–38.
Tamaki S. et al. (2002): Engraftment of sorted/expanded human central
nervous system stem cells from fetal brain,
Journal of Neuroscience Research 69(6): 976–86.
Tamaki S., Eckert K., He D. et al. (2002): Engraftment of sorted/expanded
human central nervous system stem cells from fetal brain,
Journal of Neuroscience Research 69(6): 976–86.
Tang Y., Shimizu E., Dube G.R. et al. (1999): Genetic enhancement of learning
and memory in mice, Nature 401, 6748: 63–69.
Tapp P.D., Siwak C.T (2006): The canine model of human brain aging:
cognition, behaviour, and neuropathology. In: Conn M.P. (Hg.) Handbook of
models for human Aging. Springer: Amsterdam, Boston: 415–434.
Tebbutt S.J. (2000): Technology evaluation: transgenic alpha-1-antitrypsin
(AAT), PPL therapeutics, Current Opinion in Molecular Therapy 2(2): 199–204.
Tecirlioglu R.T., Guo J., Trounson A.O. (2006): Interspecies somatic cell
nuclear transfer and preliminary data for horse-cow/mouse iSCNT,
Stem Cell Revue 2(4): 277–287.
Tetley T.D. (2007): Health effects of nanomaterials, Biochemical Society
Transactions 35, 3: 527–531.
Then C., Tippe R. (2009): Neue Runde im Tier-Monopoly: Vernehmlassung
zum Vorentwurf 2002, Bericht der Stiftung für das Tier im Recht,
Bern, 30. April 2002, http://www.tierimrecht.org/de/PDF_Files_gesammelt/
patentgesetz_vl.pdf (zuletzt aufgerufen am 23/07/10).
Then C., Tippe R. (2009): Neue Runde im Tier-MonopolyPatente auf Kuh,
Schwein, Milch und Schnitzel? Greenpeace-Recherche zu aktuellen Patent-
anträgen am Europäischen Patentamt, http://www.greenpeace.de/fileadmin/
gpd/user_upload/themen/patente_auf_leben/Report_Tier-Patente_FINAL.pdf
(zuletzt aufgerufen am 23/07/10).
Theodorou S.D., Klimentopoulou A.E., Papalouka E. (2000): Congenital
insensitivity to pain with anhidrosis. Report of a case and review of the litera-
ture, Acta orthopaedica Belgica 66 (2), 137–145.
Thompson L.H., Björklund A. (2009): Transgenic reporter mice as tools for
studies of transplantability and connectivity of dopamine neuron precursors in
fetal tissue grafts, Program in Brain Research 175: 53–79.
Thompson P.B. (2007): Food Biotechnology in Ethical Perspective. 2. Aufl.
Springer: Dordrecht.
Thompson P.B. (2008): The Opposite of Human Enhancement:
Nanotechnology and the Blind Chicken Problem, Nanoethics 2,3: 305–316.
Toth, L.A. (2000): Defining the moribund condition as an experimental
endpoint for animal research, ILAR Journal 41.
Townes T.M. (2008): Gene replacement therapy for sickle cell disease and other
blood disorders. Hematology, Am Soc Hematol Educ Program. 2008: 193–196.
Truin M., van Kleef M., Verboeket Y. et al. (2009): The effect of Spinal Cord
Stimulation in mice with chronic neuropathic pain after partial ligation of the
sciatic nerve, Pain 145(3): 312–8.
Tsai P.-P., Pachowsky U, Stelzer HD., Hackbarth H.(2002): Impact of envi-
ronmental enrichment in mice. 1: Effect of housing conditions on body weight,
organ weights and haematology in different strains,
Laboratory Animals 36: 411–419.
220 Animal Enhancement | Beiträge zur Ethik und Biotechnologie Animal Enhancement | Beiträge zur Ethik und Biotechnologie
221